Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market Projected to Reach $2.39 Billion by 2029 at a CAGR of 6.5%
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Losartan Potassium Active Pharmaceutical Ingredient (API) Market From 2025 To 2029?
In the recent past, the market size of the losartan potassium active pharmaceutical ingredient (api) has shown significant growth. It is projected to expand from a size of $1.75 billion in 2024 to $1.85 billion by the year 2025, marking a compound annual growth rate (CAGR) of 6.0%. The substantial growth observed in the historic period is due to factors such as the enhanced adoption of drugs that combat high blood pressure, a surge in lifestyle-related health conditions, increased consciousness about heart health, global rise in healthcare spending, and intensified demand for economically priced generic drugs.
In the coming years, there is an anticipated considerable growth in the market size of the Losartan Potassium active pharmaceutical ingredient (API). It is predicted to expand to $2.39 billion by 2029, with a compound annual growth rate (CAGR) of 6.5%. The projected expansion during this period can be linked to several factors such as the increasing number of patients suffering from chronic diseases, a heightened emphasis on preventive cardiac care, a rise in healthcare service penetration in developing markets, improvements in medicinal formulation technologies, and governmental initiatives promoting generic drugs. The forecast period is likely to witness trends like progress in manufacturing processes, sophisticated drug delivery systems, creation of formulations friendly for pediatric use, enhancements in packaging to lengthen shelf life, and the development of combined therapies utilizing Losartan.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24285&type=smp
What are the Fundamental Drivers and Innovations Shaping the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The increasing incidence of high blood pressure, known as hypertension, is projected to boost the expansion of the market for the active pharmaceutical ingredient (API) losartan potassium. Hypertension is a medical condition characterized by a constant elevation in blood pressure, potentially increasing the risk for heart disease, stroke, and other major health problems. The rise in hypertension cases is associated with diets high in salt and processed food, leading to fluid buildup and additional heart stress. Losartan potassium aids in managing hypertension by inhibiting angiotensin II, a hormone that constricts blood vessels. It helps in the relaxation and broadening of these vessels, subsequently reducing blood pressure and lightening the heart’s burden. For example, the American Heart Association, a nonprofit organization based in the U.S., reported in January 2024 that there were 131,454 deaths primarily attributed to high blood pressure in 2022, up from 124,508 deaths in 2021. As a result, the escalating prevalence of hypertension is fostering the growth of the losartan potassium API market.
How Is the Losartan Potassium Active Pharmaceutical Ingredient (API) Market Segmented?
The losartan potassium active pharmaceutical ingredient (api) market covered in this report is segmented –
1) By Product Type: Tablet, Capsule, Other Product Types
2) By Production Method: Synthetic Route, Biotechnological Process, Continuous Flow Production
3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications
5) By End-User: Hospitals, Clinics, Home Care Settings, Pharmaceutical Companies
Subsegments:
1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets
2) By Capsule: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules
3) By Other Product Types: Injectable Formulations, Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24285&type=smp
Which Regions Are Driving the Next Phase of the Losartan Potassium Active Pharmaceutical Ingredient (API) Market Growth?
North America was the largest region in the losartan potassium API market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan potassium active pharmaceutical ingredient (API) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Key players in the losartan potassium active pharmaceutical ingredient (API) market are directing their efforts towards creating novel products and securing approvals like that of the losartan potassium oral suspension. This tactic is aimed at enhancing patient adaptability and broadening therapeutic uses. The oral suspension version of losartan potassium offers a solution for individuals who have difficulty in swallowing tablets. For example, in March 2025, US-based biopharmaceutical enterprise Scienture Holdings Inc. garnered FDA approval for Arbli. Arbli is a ready-to-use liquid medication designed for reducing the risk of stroke in hypertensive patients with left ventricular hypertrophy, managing hypertension, and treating diabetic nephropathy in patients with type 2 diabetes. It provides accurate dosage without the need for compounding and comes in a 165 mL bottle with peppermint flavor suspension (10 mg/mL). It also boasts an 18-month shelf life at room temperature.
View the full report here:
How Is the Losartan Potassium Active Pharmaceutical Ingredient (API) Market Defined and What Are Its Core Parameters?
Losartan potassium active pharmaceutical ingredient (API) refers to the pure, active compound used in the formulation of losartan-based medications to treat high blood pressure and safeguard kidney function. It primarily manages high blood pressure, reduces the risk of heart attacks, and protects kidney function in diabetic patients.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24285
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
